Last updated on December 2018

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis


Brief description of study

This non-interventional study aims to identify key factors that are driving treatment decisions by rheumatologists in the treatment of rheumatoid arthritis (RA) patients starting treatment with Tofacitinib in a real world setting.

Clinical Study Identifier: NCT03387423

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

SRH Krankenhaus Waltershausen-Friedrichroda GmbH
Friedrichroda, Germany
  Connect »